Clinical Trial Update: Predictive Value of the Insulin-like Growth Factor-1 (IGF-1) Generation Test for the Growth Response to Growth Hormone Treatment (PRED-IGF) [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating IGF-1 generation test as predictor for growth response to GH treatment in idiopathic short stature has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Idiopathic Short Stature

Snippet

Sponsor: Ipsen | Conditions: Idiopathic Short Stature | Phase 4 | Status: WITHDRAWN